iifl-logo

Suven Life Sciences Ltd Share Price

122.04
(7.36%)
Apr 1, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open114
  • Day's High124.01
  • 52 Wk High169.3
  • Prev. Close113.67
  • Day's Low113.99
  • 52 Wk Low 82.95
  • Turnover (lac)795.96
  • P/E0
  • Face Value1
  • Book Value37.3
  • EPS0
  • Mkt. Cap (Cr.)2,661.37
  • Div. Yield0
View All Historical Data
No Records Found

Suven Life Sciences Ltd KEY RATIOS

Sector

Healthcare

Open

114

Prev. Close

113.67

Turnover(Lac.)

795.96

Day's High

124.01

Day's Low

113.99

52 Week's High

169.3

52 Week's Low

82.95

Book Value

37.3

Face Value

1

Mkt Cap (₹ Cr.)

2,661.37

P/E

0

EPS

0

Divi. Yield

0

Suven Life Sciences Ltd Corporate Action

16 Jan 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

6 May 2024

12:00 AM

AGM

Announcement Date: 06 May, 2024

arrow

6 May 2024

12:00 AM

BookCloser

arrow

Suven Life Sciences Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Suven Life Sciences Ltd SHAREHOLDING SNAPSHOT

02 Apr, 2025|08:36 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 70.26%

Foreign: 0.00%

Indian: 70.26%

Non-Promoter- 1.39%

Institutions: 1.39%

Non-Institutions: 28.34%

Custodian: 0.00%

Share Price

Suven Life Sciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

21.81

21.81

14.54

49.65

Preference Capital

0

0

0

0

Reserves

823.57

831.64

461.44

352.01

Net Worth

845.38

853.45

475.98

401.66

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

11.84

13.47

14.41

625.25

yoy growth (%)

-12.12

-6.49

-97.69

15.03

Raw materials

0

0

0

-153.7

As % of sales

0

0

0

24.58

Employee costs

-17.46

-15.28

-14.59

-58.73

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

-36.24

-27.95

-25.93

230.26

Depreciation

-4.39

-4.34

-4.16

-21.3

Tax paid

0

5.32

12.18

-71.83

Working capital

-73.46

43.42

-154.2

81.51

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-12.12

-6.49

-97.69

15.03

Op profit growth

19.95

-13.37

-115.13

40.86

EBIT growth

31.61

6.86

-110.81

42.32

Net profit growth

60.16

64.55

-108.68

28.3

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

11.69

13.54

11.84

13.48

14.41

Excise Duty

0

0

0

0

0

Net Sales

11.69

13.54

11.84

13.48

14.41

Other Operating Income

0

0

0

0

0

Other Income

28.59

14.45

5.32

7.75

14.04

Suven Life Sciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Max Healthcare Institute Ltd

MAXHEALTH

1,083.6

128.991,05,331.59138.240.14697.481.72

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

6,632.3

79.3295,327.79341.60.242,054.8569.62

Fortis Healthcare Ltd

FORTIS

688.65

257.8351,971.3239.560.15366.87120.23

Narayana Hrudayalaya Ltd

NH

1,676.8

79.8334,261.0979.220.24865.0495.32

Global Health Ltd

MEDANTA

1,231.1

84.2733,068.4899.310624.4113.49

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Suven Life Sciences Ltd

Management

Register Office

Registrar Office

Chairman & CEO

Venkateswarlu Jasti

Whole-time Director

Sudha Rani Jasti

Non Executive Director

Seyed E Hasnain

Independent Director

Santanu Mukherjee

Independent Director

J A S Padmaja

Company Sec. & Compli. Officer

Shrenik Soni

Independent Director

V Sambasiva Rao

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March, 1989. The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003. Promoted by Sudharani Jasti and Venkateswarlu Jasti, the Company began operations in 1989 as specialty chemicals provider.The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies.The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors. Suvens CRAMS provide innovative process research and development, supplies to clinical trials, rapid response pilot scale manufacture, dedicated commercial manufacturing on an exclusive basis. The services include Custom Synthesis, Process R&D, Scale Up and Contract Manufacturing of intermediates, APIs and formulations. Suven Life Sciences has graduated from contract research to Collaborative Research transitioning from project-based transactions into relationship-based business.In March 1995, SPL came out with a public issue of 9.8 lac equity shares at a premium of Rs 40 aggregating Rs 4.9 cr to part-finance the
Read More

Company FAQs

What is the Suven Life Sciences Ltd share price today?

The Suven Life Sciences Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹122.04 today.

What is the Market Cap of Suven Life Sciences Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Suven Life Sciences Ltd is ₹2661.37 Cr. as of 01 Apr ‘25

What is the PE and PB ratio of Suven Life Sciences Ltd?

The PE and PB ratios of Suven Life Sciences Ltd is 0 and 2.99 as of 01 Apr ‘25

What is the 52 Week High and Low of Suven Life Sciences Ltd?

The 52-week high/low is the highest and lowest price at which a Suven Life Sciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Suven Life Sciences Ltd is ₹82.95 and ₹169.3 as of 01 Apr ‘25

What is the CAGR of Suven Life Sciences Ltd?

Suven Life Sciences Ltd's CAGR for 5 Years at 45.45%, 3 Years at 11.70%, 1 Year at 16.23%, 6 Month at -16.42%, 3 Month at -4.60% and 1 Month at 13.83%.

What is the shareholding pattern of Suven Life Sciences Ltd?

The shareholding pattern of Suven Life Sciences Ltd is as follows:
Promoters - 70.27 %
Institutions - 1.39 %
Public - 28.34 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.